Another study based on 164 pre-treatment Asian CRC patients also found that elevated IL-6 levels in patients may be associated with a higher risk of early cancer progression in CRC, indicating that IL-6 levels may act as an important predictor for CRC progression and poor prognosis (50, 51). The gene discussed is IL6; the disease is colorectal carcinoma.